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Abstract: A considerable subset of mild traumatic brain injury (mTBI) patients fail to return to baseline
functional status at or beyond 3 months postinjury. Identifying at-risk patients for poor outcome in
the emergency department (ED) may improve surveillance strategies and referral to care. Subjects
with mTBI (Glasgow Coma Scale 13–15) and negative ED initial head CT < 24 h of injury, completing
3- or 6-month functional outcome (Glasgow Outcome Scale-Extended; GOSE), were extracted from
the prospective, multicenter Transforming Research and Clinical Knowledge in Traumatic Brain
Injury (TRACK-TBI) Pilot study. Outcomes were dichotomized to full recovery (GOSE = 8) vs.
functional deficits (GOSE < 8). Univariate predictors with p < 0.10 were considered for multivariable
regression. Adjusted odds ratios (AOR) were reported for outcome predictors. Significance was
assessed at p < 0.05. Subjects who completed GOSE at 3- and 6-month were 211 (GOSE < 8: 60%) and
185 (GOSE < 8: 65%). Risk factors for 6-month GOSE < 8 included less education (AOR = 0.85 per-year
increase, 95% CI: (0.74–0.98)), prior psychiatric history (AOR = 3.75 (1.73–8.12)), Asian/minority race
(American Indian/Alaskan/Hawaiian/Pacific Islander) (AOR = 23.99 (2.93–196.84)), and Hispanic
ethnicity (AOR = 3.48 (1.29–9.37)). Risk factors for 3-month GOSE < 8 were similar with the addition
of injury by assault predicting poorer outcome (AOR = 3.53 (1.17–10.63)). In mTBI patients seen
in urban trauma center EDs with negative CT, education, injury by assault, Asian/minority race,
and prior psychiatric history emerged as risk factors for prolonged disability.
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1. Introduction
In 2014, at least 2.5 million people were treated for traumatic brain injury (TBI) in U.S. emergency
departments (ED), of which 80%–90% were classified as “mild” (mTBI) with a Glasgow Coma Scale
(GCS) score of 13–15 [1]. The frequency of mTBI-related emergency department visits increased from
569.4/100,000 persons in 2006 to 807.9/100,000 in 2012 and continues at an increase of 7% annually [2].
While all-cause mortality for mTBI is low (1.4%) [3], patients are at significant risk of psychiatric
sequelae [4] and cognitive impairment postinjury [5]. It is estimated that 20%–70% of mTBI patients
suffer from persistent functional, cognitive and/or neuropsychological symptoms at or beyond 3 months
postinjury [6,7]. mTBI patients often suffer disruptions to functional and social wellbeing postinjury
and require greater use of healthcare resources [8]—upwards of $17 billion annually in the U.S. [9].
However, indications for referral to these necessary resources remain poorly understood, masking the
true burden of mTBI. In a recent large study of over 1.1 million adult patients who suffered TBI in the
state of California from 2005–2014, 40.5% had a revisit during the first year, and, of those revisiting
patients, 13.8% had five or more revisits within that first year [10]. A study of 2787 mTBI patients
showed that 5% returned unexpectedly to the ED within 72 h, with post-concussion symptoms or
otherwise needing repeat clinical evaluation [11]. Identifying the predictors of negative outcomes for
patients with mTBI and using this information to inform ED management strategies could improve
patient outcomes and decrease ED utilization.
The evidence-driven management of mTBI is limited compared to moderate and severe TBI, in
which additional prognostic factors have been identified due to their association with the need for
neurosurgical intervention [12]. The heterogeneous nature of mTBI and the need for guidelines in its
evaluation were demonstrated in the Transforming Research and Clinical Knowledge in Traumatic Brain
Injury Pilot (TRACK-TBI Pilot) study [13], which identified subgroups within the mTBI population
with divergent functional outcomes, persistence of symptoms, and neuropsychiatric impairment at
90 and 180 days postinjury [14]. Current ED guidelines support the utilization of GCS and pupillary
reactivity to assess and monitor severity in head injury, and computed tomography (CT) as first-line
imaging; however, these assessments are often normal or negative in mTBI patients and may not
directly correlate with post-traumatic complaints [15–17]. Data on additional clinical factors, such
as loss of consciousness (LOC), post traumatic amnesia (PTA), hypoxia, hypotension, and the use of
anticoagulants and antiplatelets, are often collected in the ED, though their clinical significance is not
well defined [9,18]. Variables not yet described in guidelines due to minimal literature but found to be
predictive of impaired outcomes following mTBI include education level and pre-injury psychiatric
history, such as anxiety and depression [4,16,19,20].
With the increasing number of mTBI patients presenting to the ED and growing evidence of
the presence of persistent post-traumatic symptomatology and disability, it is critical to identify risk
factors for adverse outcomes, update ED assessment and treatment guidelines, and improve the
efficiency of ED utilization. This is necessary to determine the appropriate level of care and services
for this heterogeneous group of individuals. In the current ED mTBI management paradigm, patients
who have a CT scan without evidence of intracranial abnormalities are routinely discharged from
the ED with return precautions. However, it has been found that only 25% return to follow-up, of
which one-third had not completely resumed pre-injury activities [21]. Thus, beyond improving
outcome, identifying mTBI patients with negative CT who are at risk for poorer outcomes can improve
ED evaluation and triage paradigms, as well as healthcare utilization. The current analysis of the
TRACK-TBI Pilot dataset sought to identify a cohort of patients in the ED with mTBI who are at greater
risk for adverse outcomes despite an initial negative head CT scan, and assess whether traditional
clinical factors measured in the ED in this patient population are adequate for predicting outcome at 3
and 6 months postinjury.
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2. Materials and Methods
2.1. Study Design of the TRACK-TBI Pilot Study
The TRACK-TBI Pilot study was conducted at three U.S. Level I trauma centers (Zuckerberg
San Francisco General Hospital (San Francisco, CA, USA), University of Pittsburgh Medical Center
(Pittsburgh, PA, USA), and University Medical Center Brackenridge (Austin, TX, USA)) using the
National Institute of Neurological Disorders and Stroke (NINDS) TBI Common Data Elements
(CDEs) [13,22–25]. The TRACK-TBI Pilot inclusion criteria were external force trauma to the head,
presentation to one of the three trauma centers, and a clinically indicated head CT scan, as determined
by the treating emergency physician, obtained within 24 h of injury. Exclusion criteria were pregnancy,
ongoing life-threatening disease (e.g., end-stage malignancy), police custody, involuntary psychiatric
hold, and inability to speak English due to limitations in participation with outcome assessments.
Eligible subjects were enrolled prospectively by trained clinical research coordinators via
convenience sampling from years 2010 to 2012. Institutional Review Board approval was obtained
at the participating sites. Informed consent was obtained prior to study enrollment. For subjects
unable to provide consent due to their injury, consent was obtained from their legally authorized
representatives. Subjects were then re-consented, if cognitively able, during the course of their clinical
care and/or follow-up visits for continued participation in the study.
2.2. Participants Included in the Current Analysis
As the goal of the current analysis was to evaluate associations between demographic, clinical and
injury factors routinely collected upon ED admission for mTBI and 3- and 6-month global functional
outcome, subjects from the TRACK-TBI Pilot were retrospectively included if they were aged ≥18 years
with an ED admission GCS score of 13–15, without evidence of intracranial injury on ED admission
head CT as determined by a blinded, central board-certified neuroradiologist, and completed 3- or
6-month Glasgow Outcome Scale-Extended (GOSE) assessment. All study personnel conducting
outcome assessments were trained in-person by a certified neuropsychology coordinator prior to study
commencement. The GOSE was completed by patient interview in all cases with the exception of
patients physically and/or cognitively debilitated to the extent where they were unable to reliably
respond to the assessment (e.g., GOSE 3 or 4, requiring assistance with activities of daily living) in
which case the designated caretaker was interviewed. Candidate predictors were included based
on their utility as described in large prior studies in mTBI [26,27], as well as capacity to be routinely
collected by ED personnel for patients with mTBI. Demographic factors, such as race, ethnicity and
education level, and clinical factors, such as prior psychiatric history, were self reported.
2.3. Outcome Measure
The GOSE is a measure of functional disability covering cognition, independence, employability,
and social/community participation. It is assessed via structured interview and has been widely used
as a standard outcome measure for TBI [28,29]. Subjects are assigned one of eight categories: 1 = dead,
2 = vegetative state, 3 = lower severe disability, 4 = upper severe disability, 5 = lower moderate
disability, 6 = upper moderate disability, 7 = lower good recovery, and 8 = upper good recovery (return
to baseline function). The GOSE is anchored to baseline functional status; for instance, patients who
returned to their baseline level of physical, mental health and/or socioeconomic status were scored as
GOSE = 8. Patients with additional physical, cognitive, functional and/or social integration burden
after TBI were scored as GOSE < 8, accordingly.
For the current analysis, 3- and 6-month GOSE outcomes were dichotomized to full return to
baseline function (GOSE = 8) versus presence of functional deficits (GOSE < 8). By definition, a GOSE
of 7 implies deficits in resumption of social activities, problems with social integration, and persistent
postconcussive symptoms resulting in functional impairment compared to baseline. Recent studies
have suggested that there are distinct neuropsychological differences between the GOSE 7 and GOSE
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8 groups, more specifically the prominence of neurocognitive impairment in the GOSE 7 group,
suggesting that “good recovery” for GOSE 7 patients may be misleading especially after mTBI [30].
2.4. Statistical Analysis
Descriptive statistics are presented as medians and interquartile range (IQR) for continuous
variables and proportions for categorical variables. Group differences were assessed using the
Wilcoxon Rank Sum test for continuous variables and Fisher’s exact test for categorical variables.
Univariate predictors with p < 0.10 were included in multivariable regression models, with the
exception of those with cell counts of 0 on univariate analyses due to limitations on model performance.
AOR for multivariable logistic regressions to predict 3- and 6-month functional deficits, and their
associated 95% confidence intervals (CI), were reported for each predictor in the regression analyses.
Significance was assessed at p < 0.05. All analyses were performed using R [31] version 3.5.1.
3. Results
Overall, there were 271 eligible subjects with GCS 13–15 without evidence of intracranial injury
on emergency department head CT. The majority of patients were male (69.4%) and white (73.4%).
The median age was 39 years, IQR ranging from 26 to 52 years. The GCS distribution of these patients
was: 15 (74.9%), 14 (22.1%), 13 (3.0%). The median years of education was 14 years (IQR: 12–16 years).
Psychiatric history was noted as present for 37.3% of the patients. Nearly all patients (99.6%) had
sustained a closed TBI. Motor vehicle accidents accounted for 35.8% of total injuries, falls accounted for
27.3%, bicycle accidents accounted for 20.7%, and assaults accounted for 18.1% of injuries. LOC was
present in 51.3% of patients and PTA was present in 49.4% of patients. The prevalence of ED hypoxia
and ED hypotension was 4.8% and 1.1%, respectively. Of the 271 eligible mTBIs, 211 completed 3-month
outcomes and 185 completed 6-month outcomes. Subjects who completed the outcome assessments
were similar in baseline characteristics to those who missed the assessments at 3 or 6 month postinjury.
At 3-months, 60.2% of subjects (n = 127) and at 6-months, 65.4% (n = 121) had functional deficits (GOSE
< 8). The flowchart of included subjects is presented in Figure 1.
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3.1. Univariate Predictors of 3- and 6-Month GOSE
Based on univariate analysis (Table 1), at the 3-month outcome, years of education were significantly
lower in subjects with functional deficits (GOSE < 8) compared with those without functional deficits
(GOSE = 8) (median 13 vs. 15, p < 0.01). A greater proportion of subjects with a baseline psychiatric
history (e.g., anxiety, depression, post-traumatic stress, bipolar disorder, schizophrenia, sleep disorders,
and others) had functional deficits compared with those without a psychiatric history (72% vs. 53%,
p < 0.01). Individuals who suffered from assault as the mechanism of injury were more likely to have
functional deficits than those with injuries from falls or accidents (81% vs. 56%, p = 0.01). A greater
proportion of Asian (86%), American Indian or Alaskan (100%), and Hawaiian or Pacific Islander
(100%) participants had functional deficits, compared to Caucasian participants (54%, p = 0.015).
A nonsignificant statistical trend was observed for subjects with pre-hospital hypoxia more likely to
have functional deficits compared with subjects without pre-hospital hypoxia (100% vs. 58%, p = 0.08).
These results persist and remain significant at the 6-month GOSE measurement (Table 1) with the
addition that Hispanic subjects had greater functional deficits, compared with non-Hispanic subjects
(81% vs. 61%, p = 0.03).
No statistical associations were observed of functional deficits on 3- or 6-month GOSE < 8 vs.
GOSE = 8 with gender, GCS, anticoagulant use, LOC, PTA, pre-hospital hypotension, urine toxicology
screen, blood alcohol level, ED hypotension, or ED hypoxia.
3.2. Multivariable Predictors of 3- and 6-Month GOSE
On multivariable analysis at 3 months (Table 2), significant risk factors associated with worse
outcome included fewer years of education (AOR = 0.88 per year increase in education, 95%
CI: 0.78–0.998, p = 0.046), the presense of psychiatric history (AOR 2.30, 95% CI: 1.18–4.49, p = 0.015),
being Asian, American Indian or Alaskan, Hawaiian, or Pacific Islander (AOR = 12.40, 95% CI: 2.66–57.77,
p = 0.006). Assault as the mechanism of injury was also associated with an increased odds of functional
deficit (AOR = 3.53, 95% CI: 1.17–10.63, p = 0.025).
Risk factors for functional deficits at 6 months postinjury were similar (Table 2). Lower education
and the presense of psychatric history were associated with higher odds of worse outcome. Hispanic
ethnicity was also a predictor for 6-month deficits (AOR = 3.48, 95% CI: 1.29–9.37, p = 0.01).
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Table 1. Univariate associations between demographic and clinical characteristics and functional deficits at 3 and 6 months.
3 Months, n = 211 6 Months, n = 185
Variable GOSE < 8(n = 127)
GOSE = 8
(n = 84) p-Value
GOSE < 8
(n = 121)
GOSE = 8
(n = 64) p-Value
Age Years (med, IQR) 40 26–54 36 26–50 0.30 40 26–52 35 24–51 0.37
Gender
Male 84 59% 59 41% 0.55 79 63% 46 37% 0.41
Female 43 63% 25 37% 42 70% 18 30%
Race
Caucasian 83 54% 72 46% 0.02 80 60% 54 40% 0.07
African American or African 18 75% 6 25% 15 75% 5 25%
Asian 12 86% 2 14% 12 92% 1 8%
American Indian or Alaskan 2 100% 0 0% 2 100% 0 0%
Hawaiian or Pacific Islander 2 100% 0 0% 4 100% 0 0%
More than One Race 6 60% 4 40% 7 64% 4 36%
Not Available 1 100% 0 0% 1 100% 0 0%
Ethnicity Non-Hispanic 96 58% 70 42% 0.23 91 61% 57 39% 0.03
Hispanic 31 69% 14 31% 30 81% 7 19%
Years of Education Years (med, IQR) 13 12–16 15 12.5–16 0.006 14 12–16 15 13–16.5 0.002
Psychiatric History No 72 53% 63 47% <0.01 63 56% 50 44% <0.001
Yes 55 72% 21 28% 58 81% 14 19%
Injury Mechanism Fall/Accident/Other 101 56% 78 44% 0.01 95 62% 59 38% 0.02
Assault 26 81% 6 19% 26 84% 5 16%
Glasgow Coma
Scale
13 5 71% 2 29% 0.81 5 100% 0 0% 0.22
14 28 62% 17 38% 24 60% 16 40%
15 94 59% 65 41% 92 66% 48 34%
Anticoagulant Use No 120 60% 79 40% >0.99 112 65% 61 35% 0.55
Yes 7 58% 5 42% 9 75% 3 25%
Loss of
consciousness
None 39 61% 25 39% 0.58 31 60% 21 40% 0.75
< 30 min 54 57% 41 43% 59 69% 27 31%
≥ 30 min 4 50% 4 50% 7 64% 4 36%
Unknown 30 68% 14 32% 24 67% 12 33%
Post-traumatic
amnesia
None 48 61% 31 39% 0.66 45 63% 26 37% 0.61
< 30 min 41 56% 32 44% 39 66% 13 34%
≥ 30 min 21 60% 14 40% 20 61% 13 39%
Unknown 17 71% 7 29% 17 77% 5 23%
Pre-hospital
hypotension
(SBP < 90)
No 96 58% 69 42% 0.47 83 60% 56 40% 0.15
Yes 6 75% 2 25% 7 88% 1 13%
Unknown 25 66% 13 34% 31 82% 7 18%
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Table 1. Cont.
3 Months, n = 211 6 Months, n = 185
Variable GOSE < 8(n = 127)
GOSE = 8
(n = 84) p-Value
GOSE < 8
(n = 121)
GOSE = 8
(n = 64) p-Value
Pre-hospital
hypoxia
(SpO2 < 90)
No 96 58% 70 42% 0.08 85 60% 56 40% 0.28
Yes 5 100% 0 0% 3 100% 0 0%
Unknown 26 65% 14 35% 33 80% 8 20%
Urine toxicology
screen
Negative 120 61% 78 39% 0.77 113 65% 62 35% 0.5
Positive 7 54% 6 46% 8 80% 2 20%
Blood alcohol level
Negative 27 60% 18 40% 0.66 23 62% 14 38% 0.41
Positive 16 70% 7 30% 18 78% 5 22%
Not obtained 84 59% 59 41% 80 64% 45 36%
ED hypotension
No 125 60% 83 40% >0.99 119 65% 64 35% 0.55
Yes 1 50% 1 50% 2 100% 0 0%
Unknown 1 100% 0 0% 0 0% 0 0%
ED hypoxia
No 120 60% 81 40% >0.99 116 65% 62 35% >0.99
Yes 5 63% 3 38% 4 67% 2 33%
Unknown 2 100% 0 0% 1 100% 0 0%
Caption: ED—emergency department; IQR—interquartile range; GOSE—Glasgow Outcome Scale—Extended; SBP—systolic blood pressure; SpO2—oxygen saturation measured by pulse
oximetry. Bold font designates p < 0.05.
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Table 2. Multivariable analysis of Risk Factors for 3- and 6-month functional deficits (GOSE < 8).
Risk Factors
GOSE < 8 vs. GOSE = 8 at 3 Months
Postinjury
GOSE < 8 vs. GOSE = 8 at 6 Months
Postinjury
AOR (95% CI) P-Value AOR (95% CI) P-Value
Years of Education 0.88 (0.78–0.998) 0.046 0.85 (0.74–0.98) 0.026
Psychiatric History
No 1
0.015
1
0.001Yes 2.30 (1.18–4.49) 3.75 (1.73–8.12)
Injury Mechanism
Fall/Accident/Other 1
0.025
1
0.054Assault 3.53 (1.17–10.63) 3.41 (0.98–11.85)
Race
White 1
0.006
1
0.025
Black 2.53 (0.82–7.83) 1.77 (0.48–6.51)
Asian/Other 12.40 (2.66–57.77) 23.99 (2.93–196.84)
More than one race 0.88 (0.20–3.84) 1.03 (0.22–4.70)
Ethnicity
Non-Hispanic 1
0.124
1
0.014Hispanic 1.84 (0.85–4.02) 3.48 (1.29–9.37)
Caption: GOSE—Glasgow Outcome Scale—Extended; AOR—adjusted odds ratio.
4. Discussion
This study is one of very few to examine the association of baseline clinical factors with postinjury
functional outcomes in a cohort of mTBI patients presenting to EDs of Level 1 trauma centers with
a negative head CT. Education level, pre-injury psychiatric history, assault as the mechanism of
injury, Asian race and other minorities (American Indian or Alaskan, Hawaiian or Pacific Islander),
and Hispanic ethnicity were predictive of heightened risk for functional deficits at three or six months
postinjury [4,6,20,26,32–38]. Although there is a pervasive belief that all TBI will get better with
time [39,40]. We found that the proportion of participants with functional deficits did not decrease
from 3 to 6 months in patients who returned for follow-up. Therefore, modification of existing ED
assessment and treatment guidelines to highlight the needs of these patients and provide appropriate
referral to follow-up at earlier time points could prove beneficial.
Our finding that over 60% of patients with CT-negative, GCS 13–15 TBI have functional deficits
at 3 and 6 months aligns with findings over the past decade that the proportion of deficits in mTBI
patients is higher than traditionally appreciated [7,41]. Notably, commonly cited risk factors for poor
outcome in severe TBI such as pre-hospital hypoxia and hypotension [42–45], were rarely seen in
this cohort of patients who inherently have “milder” injuries, and factors used in ED guidelines such
as LOC and PTA [46] were not associated with outcome. However, a negative CT with a GCS of
13–15 does not necessarily portend that the patient will recover to baseline after a short period of
cognitive rest—in fact, a subset of these patients likely require increased surveillance and strict return to
activity precautions. Our finding that GOSE deficits associated with a pre-injury history of psychiatric
conditions were maintained at three and six months suggests that longer follow-up both in clinical
settings and in research design may be critical in order to refer for treatment and obtain accurate
outcome assessments, respectively.
Despite the evidence of persistent symptoms months to years postinjury [47–50] a large proportion
of mTBI patients do not receive follow-up care. In a study of 831 mTBI patients, only 42% received
TBI educational materials at ED discharge [51] despite evidence that patient educational information
and targeted follow-up have been shown to reduce post-concussive symptoms [52–55]. In this same
cohort, nearly 40% of CT-positive, mTBI patients had not seen a physician by three months following
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injury [51]. Even in those with persistent symptoms, only 41% were seen by a practitioner by two weeks
and 44% by three months [51].
The ED physician is uniquely positioned to stratify patients that are in greater need of support
and resources given that the majority of the triage, work-up, and injury education of mTBIs occur in
the ED, and the vast majority of mTBI patients are discharged directly from the ED. Currently, patient
education level and pre-injury psychiatric history information are not routinely collected in the ED.
Mechanism of injury, race, and ethnicity are frequently collected in the ED; however, these factors rarely
inform decision making after TBI. Including the assessment of these evidence-based clinical factors in
the guidelines for ED management of mTBI would trigger appropriate referral for the patients most
likely to develop persistent sequelae and demonstrate the justification for more accessible services.
Resources such as social work, follow-up referrals, and patient education regarding mTBI are sparse
compared with those available for moderate and severe TBI [56,57]. One potential method to improve
follow-up is to ensure ED social workers discuss follow-up with patients prior to discharge [58]. While
treatment for mTBI remains variable, evidence has shown that cognitive rehabilitation, psychosocial
support, and consistent follow-up with specialists can reduce symptomatology, decrease the time
needed to return to work or baseline social integration, and improve the quality of life [59–62]. Utilizing
existing infrastructure, such as patients’ primary care physicians, to improve follow-up when the
brain is most receptive to rewiring [63,64], could help alleviate both post-concussive symptoms and
observed long-term effects, such as neurocognitive decline [65,66].
Limitations
We recognize several limitations to our analysis. We analyzed mTBI patients from a convenience
sample that may not be representative of the entire mTBI population. We also recruited from U.S.
Level I trauma centers, which predominantly care for patients with more severe injuries and a greater
likelihood of comorbidities. We focused on investigating variables routinely collected as part of ED
admission that may be of value in overall functional recovery, and did not analyze for trajectories
of recovery, which would be a prime topic for future investigations. The number of participants in
non-White racial groups is small. Variables such as pre-hospital hypoxia also suffered from low cell
counts on univariate analyses and were not included in multivariable models. Therefore, associated
odds ratios should be interpreted cautiously, and will benefit from confirmation in future studies of ED
patient populations with mTBI. As with all trauma studies, we were limited to patients who returned
for follow-up, and attrition bias limits the generalizability of our study. Toxicology and blood alcohol
level data were subject to institutional limitations and were not routinely drawn on all mTBI patients,
which limits generalizability.
As the TRACK-TBI Pilot study variables were based on version 1 of the NINDS CDEs, insurance
status, readmission, and granular post-discharge data were not available. Accordingly, post-acute
interventions such as referrals and/or rehabilitation were not available. As we analyzed patients who
were discharged from the ED, polytrauma was not categorized by the trauma registry, which is only
available for admitted patients; however, this is likely a minor contribution, as patients’ peripheral
injuries were deemed safe for discharge directly from the ED. Whether patients received TBI education
materials is another data point informative for outcomes analysis [51] and was not tracked as part of
the TRACK-TBI Pilot. These variables are being collected as part of the ongoing 18-center Transforming
Research and Clinical Knowledge in Traumatic Brain Injury study [67] using version 2 of the NINDS
TBI CDEs [68].
Regarding future directions, facilitating education and managing psychiatric issues may help
reduce exposure and improve adherence to mTBI follow-up [51,52]. Comparison to military studies
will also be of use, as the presence of psychiatric comorbidities, e.g., post-traumatic stress disorder
(PTSD), consistently predicted poorer post-deployment outcome in deployed veterans compared to
veteran controls, while demographics and injury mechanisms were less important [69–71]. This may be
related to factors of intensity, and the frequency of trauma in military compared to civilian populations,
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as well as measures of resilience [72], which are ongoing topics of research. The implementation of
qualified biomarkers sensitive to the presence of CT abnormalities can also improve diagnosis and the
need to triage to follow-up for ED patients with mTBI [73,74].
5. Conclusions
In summary, it is our responsibility to implement compensatory resources and services for the
over 65% of CT-negative mTBI patients who may predictably have functional deficits in the three to six
months postinjury. The predictors of education, assault as the mechanism of injury, minority races,
and the presence of baseline psychiatric disorders can be routinely collected at ED admission without
significant burden to the provider or patient. These patients may benefit from education, follow-up
resources, necessary referrals and/or early surveillance in clinic. Education, psychiatric history, race
and ethnicity, along with mechanism of injury, should be considered for integration into current ED
mTBI protocols.
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